septerna - Search News

News

Novo Nordisk Inks A Major Obesity Deal

The Wall Street Journal on MSN · 8h

Novo Nordisk and Septerna Strike $2.2 Billion Deal to Develop Obesity Pills

The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other cardiometabolic diseases.

Bloomberg on MSN · 1d

Novo Nordisk, Septerna Agree $2.2 Billion Obesity Pill Deal

Novo Nordisk A/S is partnering with US biotech Septerna Inc. on the development of oral pills for obesity in a deal potentially worth up to $2.2 billion.The two companies will start with four development programs that use different ways to potentially treat obesity,

Seeking Alpha on MSN · 1d

Novo Nordisk in pact with Septerna for oral obesity drugs

Septerna (SEPN) stock surges as Novo Nordisk (NVO) inks $2.2B deal to develop and commercialize oral obesity drugs. Read more here.

Novo Nordisk strikes deal with Septerna to develop obesity pills

Novo Nordisk is partnering with the biotech Septerna to develop oral obesity drugs, as it aims for more convenient weight ...

1d

Novo Nordisk, Septerna sign $2.2B deal to develop weight-loss pill

Pharmaceutical giant Novo Nordisk (NVO) inks a $2.2 billion deal with biotech company Septerna (SEPN) to develop a GLP-1 ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results